Phenol

Phenol

SCHEMBL4337822

Cc1cc(C)n(-c2ccccc2-n2nc(C)cc2C)n1.Oc1ccccc1.[Pt]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
GAA P10253 3/20 0.58
TSHR P16473 3/20 0.46
TDP1 Q9NUW8 2/20 0.45
POLB P06746 2/20 0.45
USP2 O75604 1/20 0.45
ALOX15 P16050 1/20 0.45
PTPN7 P35236 1/20 0.45
CREBBP Q92793 1/20 0.45
MAPT P10636 7/20 0.44
MAPK1 P28482 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
XBP1 P17861 1/20 0.44
NTSR1 P30989 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4336653 0.87 KDM4E (0.64) KDM4EGAATSHRTDP1POLB
Hydrochloric Acid SCHEMBL4336655 0.83 KDM4E (0.64) KDM4EGAATSHRTDP1POLB
SCHEMBL2052349 0.82 KDM4E (0.67) KDM4EGAATSHRTDP1POLB
Bicarbonate SCHEMBL17255684 0.80 KDM4E (0.59) KDM4EGAATSHRTDP1POLB
Phenol SCHEMBL4337824 0.79 KDM4E (0.55) KDM4EGAATSHRTDP1POLB
SCHEMBL17255696 0.76 KDM4E (0.58) KDM4EGAATSHRMAPTHSD17B10
SCHEMBL17255679 0.76 KDM4E (0.62) KDM4EGAATSHRMAPTMAPK1
SCHEMBL17033294 0.75 KDM4E (0.58) KDM4EGAATSHRTDP1POLB
SCHEMBL12528207 0.75 KDM4E (0.65) KDM4EGAATSHRTDP1POLB
SCHEMBL597831 0.74 MAPT (0.57) KDM4EGAATDP1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9082989-B2 Platinum (II) di (2-pyrazolyl) benzene chloride analogs and uses Arizona Board of Regents for and on behalf of Arizona State Univesity (US) 2015-07-14 US disclosed
US-8846940-B2 Platinum (II) di (2-pyrazolyl) benzene chloride analogs and uses ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2014-09-30 US disclosed
US-20140066628-A1 Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2014-03-06 US disclosed
US-20110301351-A1 Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2011-12-08 US disclosed
WO-2009086209-A2 PLATINUM(II) DI(2-PYRAZOLYL)BENZENE CHLORIDE ANALOGS AND USES ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301351-A1 Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses PDCD1LG2, PDCD2L, IDH1 KDM4E 3941/4885GAA 4558/4885TSHR 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.